Summary and concluding remarks

M. Packer

doi:10.1159/000176435

Summary and concluding remarks

M. Packer

Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	427-428
Number of pages	2
Journal	Cardiology (Switzerland)
Volume	84
Issue number	6
DOIs	https://doi.org/10.1159/000176435
State	Published - 1994

Keywords

Angiotensin-converting enzyme inhibitors
Assessment of treatment with lisinopril and survival (ATLAS)
Clinical practice
Clinical trials
Lisinopril

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1159/000176435

Cite this

@article{d5fb6a2aaee94b9ca37df9ea73cba08e,

title = "Summary and concluding remarks",

keywords = "Angiotensin-converting enzyme inhibitors, Assessment of treatment with lisinopril and survival (ATLAS), Clinical practice, Clinical trials, Lisinopril",

author = "M. Packer",

year = "1994",

doi = "10.1159/000176435",

language = "English (US)",

volume = "84",

pages = "427--428",

journal = "Cardiology (Switzerland)",

issn = "0008-6312",

publisher = "S. Karger AG",

number = "6",

}

TY - JOUR

T1 - Summary and concluding remarks

AU - Packer, M.

PY - 1994

Y1 - 1994

KW - Angiotensin-converting enzyme inhibitors

KW - Assessment of treatment with lisinopril and survival (ATLAS)

KW - Clinical practice

KW - Clinical trials

KW - Lisinopril

UR - http://www.scopus.com/inward/record.url?scp=0028357561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028357561&partnerID=8YFLogxK

U2 - 10.1159/000176435

DO - 10.1159/000176435

M3 - Article

AN - SCOPUS:0028357561

SN - 0008-6312

VL - 84

SP - 427

EP - 428

JO - Cardiology (Switzerland)

JF - Cardiology (Switzerland)

IS - 6

ER -

Summary and concluding remarks

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this